Clinical Trial Update: Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation [EARLY_Phase 1]

View source ↗

Summary

A phase 1 pilot trial evaluating pembrolizumab for relapse after allogeneic stem cell transplantation in patients with classical Hodgkin lymphoma and B-cell non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• B-cell Non-hodgkin Lymphoma
• Classical Hodgkin Lymphoma
• Myelodysplastic Syndromes

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Chicago | Conditions: Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-04-22